The tyrosine kinase activity of the insulin receptor was examined with partially-purified insulin receptors from adipocytes obtained from 13 lean nondiabetics, 14 obese nondiabetics, and 13 obese subjects with non-misulin-dependent diabetes (NIDDM). Incubation of receptors at 4VC with h'-32PIATP and insulin resulted in a maximal 10-12-fold increase in autophosphorylation of the 92-kDa ,8-subunit of the receptor with a half maximal effect at 1-3 ng/ml free insulin. Insulin receptor kinase activity in the three experimental groups was measured by means of both autophosphorylation and phosphorylation of the exogenous substrate Glu4:Tyrl. In the absence of insulin, autophosphorylation and Glu4:Tyrl phosphorylation activities, measured with equal numbers of insulin receptors, were comparable among the three groups. In contrast, insulin-stimulated kinase activity was comparable in the control and obese subjects, but was reduced by '50% in the NIDDM group. These findings indicate that the decrease in kinase activity in NIDDM resulted from a reduction in coupling efficiency between insulin binding and activation of the receptor kinase. The insulin receptor kinase defects observed in NIDDM could be etiologically related to insulin resistance in NIDDM and the pathogenesis of the diabetic state.
Introduction
It is well accepted that the binding of insulin to specific cell surface receptors activates certain transmembrane and intracellular signaling mechanisms important in coupling insulin binding to insulin action. The details of these proposed molecular signals have not been clarified, however it has been suggested that phosphorylation and dephosphorylation of cellular proteins may play a role (1) (2) (3) . This notion has received support from in vitro studies showing that the highly purified insulin receptor is a heterotetrameric glycoprotein comprised of two subunits: an a subunit that contains the major insulin binding domain of the receptor, and a subunit that expresses insulin-stimulative kinase activity directed toward its own tyrosine residues (4) (5) (6) . This autocatalytic reaction also serves to activate the insulin receptor kinase toward tyrosine-containing, nonreceptor substrates (7) (8) (9) (10) . These findings have been largely made in cell-free systems, however similar findings have been observed in intact cells. These combined results have led to the speculation that in intact cells, insulin binding rapidly activates the insulin receptor tyrosine kinase toward biologically important intracellular substrates, thereby coupling insulin binding to some or all ofinsulin's biologic effects.
In support of a role for the insulin receptor kinase in the biologic actions of insulin, several investigators have demonstrated altered kinase activity of insulin receptors isolated from humans and laboratory animals with altered insulin action. For example, Grunberger et al. (14) and Grigorescu et al. (15, 16) studied insulin binding and insulin receptor kinase activity in insulin receptors partially purified from cells of patients with severe insulin-resistant Type A diabetes. Their results in monocytes, erythrocytes, and cultured fibroblasts indicated that most patients with this disorder demonstrated a reduction in kinase activity. In some patients, this reduction was due to a reduction in insulin receptors but in others, it was due to a decrease in intrinsic kinase activity per receptor. In diabetic animals, Kadowaki et al. (17), using liver, and more recently Burant et al. (18) , studying hindlimb muscle, found decreased intrinsic receptor kinase activity, in insulin receptors partially purified from experimentally diabetic rats. LeMarchand-Brustel et al. (19) found a similar reduction in kinase activity in skeletal muscle from mice rendered obese and diabetic by gold thioglucose administration. In another study, we reported decreased intrinsic kinase activity of hepatic insulin receptors after 3 d of fasting, a condition associated with reduced insulin action, and increased kinase activity in rats fed high-carbohydrate diets, a regimen that produces an increase in insulin action (20) . Taken together, these studies suggest a possible role for the insulin receptor kinase in insulin action and indicate that alterations in receptor kinase activity may occur in states of insulin resistance.
Insulin resistance is a prominent feature ofboth human obesity (21-24) and non-insulin-dependent diabetes mellitus (NIDDM)1 (24) (25) (26) . Some ofthis insulin resistance is accounted for by a reduction in insulin binding to its receptor, however the major component is attributed to a post-binding defect in insulin action. Defects have been described in the glucose transport system and at several intracellular metabolic sites in isolated adipocytes and skeletal muscle from subjects with both NIDDM (25, 27, 28) and obesity (29) (30) (31) (32) . Studies in which insulin binding has been correlated with in vivo measurements of glucose disposal have revealed decreased coupling of insulin binding to action in NIDDM (33) but not obesity (22) . This finding suggests that the insulin resistance ofobesity differs from that ofNIDDM.
The isolated adipocyte has proved a useful model to investigate insulin action in NIDDM and obesity. It is a well-studied target tissue for insulin, and adequate amounts of tissue for study can be obtained under local anesthesia. Moreover, the isolated adipocyte mirrors the insulin resistance observed in vivo (25, 32 The following reagents were purchased from Sigma Chemical Co., St. Louis, MO: HEPES, Triton X-100, N-acetyl-D-glucosamine, ATP, cytosine triphosphate (CTP), phenylmethylsulfonyl fluoride (PMSF), poly (Glu-Tyr) (Glu4:Tyrl), phosphoamino acid standards, and polyethylene glycol. All materials for protein determination and sodium dodecyl sulfate gel electrophoresis (SDS-PAGE) were from Bio-Rad Laboratories, Richmond, CA.
Patients. The study population consisted of 40 paid volunteers recruited on the basis of body weight, history of diabetes, fasting blood glucose, and results of prior glucose tolerance tests. All subjects were admitted to the Veterans Administration Medical Center in La Jolla, CA, and informed consent was obtained. Subjects were given 3 d of a solid isocaloric diet followed by an overnight fast and a standard 75-g 4-h oral glucose tolerance test (OGTT). They were subsequently classified as having either normal glucose tolerance or NIDDM, based upon criteria established by the National Diabetes Data Group (34). Thirteen subjects had NIDDM, 27 had normal glucose tolerance. The subjects with NIDDM had a mean age (±SEM) of 53.6±3.3 yr and had evidence of overt diabetes for a mean duration of 12.2±2.4 yr. Six were previously untreated, two had received previous insulin therapy, and five had been given sulfonylurea agents in the past (Table I) . Among these subjects, insulin and sulfonylurea agents were withdrawn with consent at least 3 wk before entry into the study. Based upon relative body mass indices (BMI), all ofthe diabetic subjects were considered obese (BMI = 37.5±2.5 kg/M2). The nondiabetic subjects were also subdivided on the basis of BMI, and this group of 27 patients was comprised of 13 lean subjects were preincubated in the absence and presence of 2.5, 10, and 500 ng/ ml unlabeled insulin for 18 h at 4°C in a total volume of 40 Ml. To initiate the phosphorylation reaction, 10 Ml of the exogenous substrate Glu4:Tyrl (final concentration, 2 mg/ml) and 10 ,l of a mixture calculated to give final concentrations of 5 mM MnC12, 12 mM MgCl2, 500MuM CTP, and 50MuM [y-32P]ATP ('-5 MuCi/nmol) were added. After incubation at 4°C for different intervals of time, the reaction was terminated by the addition of 50 mM ATP, and the 32p incorporated into Glu-Tyr was determined by the filter paper method, as previously described (39) . Radioactivity, measured in the absence ofpeptide, was used to assess the background and generally was <10% of the basal activity measured in the presence of peptide.
Measurement ofA TPase activity. Insulin receptor preparations were preincubated with 500 ng/ml insulin under conditions identical to those described for the autophosphorylation reactions. Additional incubates without receptors were prepared using buffer A with 0.3 M N-acetyl-Dglucosamine. After 18 h at 4°C, [-y-32P]ATP (50 MM, I MACi), 5 mM MnCl2 and 4 mM MgCl2 were added, with and without 500 MM CTP (final concentration). 10-ul aliquots were withdrawn at various times and added to 2 ml of 50 mM KH2PO4 containing 0.1 g Norit A charcoal.
The reaction mixture was vigorously vortexed and the charcoal pelleted by centrifugation (500 g, 5 min). The percent of total radioactivity remaining in the charcoal-free supernatant was taken as 32P hydrolyzed from ATP (40).
Photolabeling ofNAPA-'25I-insulin to intact adipocytes. Freshly isolated adipocytes, pH 7.4, were incubated at 16°C for 30 min with a saturating concentration (40 ng/ml) of the photoactive compound NAPA-'251I-insulin in the presence or absence of an excess amount of unlabeled insulin after which the cells were exposed to UV radiation (336 nm) for 3 min at 4°C to effect chemical crosslinking, as previously detailed (41). Noncovalently bound NAPA-insulin was subsequently removed by washing, and the cells were solubilized and boiled in (final concentrations) 1.5% SDS, 0.5 mM N-ethylmaleimide, and 1 mM PMSF in the absence and presence of 100 mM dithiothreitol. The proteins were analyzed on a 5-15% continuous SDS-polyacrylamide gel, and the labeled proteins were located by autoradiography.
Data analysis. All values are given as the mean±SEM. Repeated measures, two-way analysis of variance and Duncan's multiple range test were employed for statistical evaluation of the results of the glucose tolerance tests and receptor kinase studies in the three experimental groups. For all other measurements, the Student's t test was used.
Results
The characteristics ofthe subjects are displayed in Table I . Obese and NIDDM subjects were significantly older (P < 0.01) and fatter (P < 0.01) than the lean controls but were not statistically different in age or BMI from each other. Fasting levels of glucose were elevated relative to control subjects only in the NIDDM group. Fasting levels ofinsulin were elevated relative to controls in both the NIDDM and obese subjects. The full results of the oral glucose tolerance tests used to classify subjects as diabetic or nondiabetic are illustrated in Fig. 1 (42, 43) and adipocytes (25, 28) . The approximate yield ofreceptors recovered per gram of fat was lower in both the obese and NIDDM subjects compared with the controls (-246 fmol insulin-binding capacity/g in controls, -124 fmol/g in the obese, and -99 fmol/g in the NIDDM subjects). Thus, to obtain similar numbers of total receptors, more fat was generally extracted from the obese and NIDDM subjects than from the lean controls (10.3±0.7 g in controls, 16 receptor (44) . To emphasize this relationship, the phosphorylation data of Fig. 3 B were recast as a function of fractional receptor occupancy (Fig. 3 C) rather than the concentration of added insulin. Fig. 4 A illustrates the time dependency of autophosphorylation in control, obese, and NIDDM subjects. Equal numbers of insulin receptors in all three groups were preexposed to a maximally stimulating concentration of insulin. Subsequent autophosphorylation in all three groups was linear for -30 min, with half-maximal incorporation of 32P by 30-35 min, and a maximal effect by -120 min. At all times, the amount of 32p incorporated into the #3 subunit of the receptor was similar in the control and obese subjects but reduced by >50% in the NIDDM subjects. Phosphorylation reactions in intact cells exposed to insulin have documented that phosphorylation of both tyrosine and serine residues in the subunit occurs, whereas tyrosine residues are phosphorylated predominantly in cell-free systems (12). To assess phosphorylation patterns in the human adipocyte receptor systems, phosphoamino acid analysis was performed with receptors autophosphorylated in vitro in the presence of insulin. As shown in Fig. 4 B, 32P incorporation occurred exclusively on tyrosine residues in all three groups.
In addition to this comparison ofmaximal insulin-stimulated 32p incorporation, autophosphorylation was also measured over a range of insulin concentrations, and the results are displayed in Fig. 5 Fig. 5 reflect only insulin-stimulated autophosphorylation. When equal amounts of insulin receptors were allowed to autophosphorylate, the amount of phosphate incorporated into the subunit ofthe receptor was similar in the lean controls and nondiabetic obese subjects at all insulin concentrations. In contrast, the amount of autophosphorylation was markedly reduced (P < 0.01 by two-way analysis of variance) over a range of insulin concentrations in the NIDDM subjects relative to the two other groups. The concentration of insulin that produced a half-maximal stimulation of autophosphorylation was comparable in the three groups and occurred at 2.8±0.2, 3.0±0.3, and 3.2±0.2 ng/ml in the control, obese, and NIDDM, respectively. At maximally stimulating concentrations of insulin, the mean autokinase activity of the receptors from NIDDM was 46% (P < 0.05) less than in the lean controls and 43% less (P < 0.05) than the obese nondiabetics.
Autophosphorylation activity is determined by measuring the amount of32p incorporated into the #3 subunit ofthe receptor. course of insulin-stimulated phosphorylation of Glu4:Tyrl was measured using equal numbers ofreceptors from all three groups. The results, demonstrated in Fig. 7 , revealed linear phosphorylation rates for 2-3 h in all three groups, but the rate of Glu4: Tyrl phosphorylation was significantly slower in the NIDDM subjects compared with the control and obese, nondiabetic subjects. A full insulin dose-response curve for Glu4:Tyrl phosphorylation is illustrated in Fig. 8 and these values were subtracted from the corresponding insulinstimulated values. Therefore, the results, displayed in Fig. 8 A, directly illustrate the ability of insulin to augment Glu4:Tyrl kinase activity over basal. Insulin-stimulated phosphorylation of Glu4:Tyrl was similar in the controls and nondiabetic obese groups but was significantly reduced (P < 0.01 by two-way analysis of variance) in the NIDDM subjects over the entire range of insulin concentrations. At maximally stimulating concentrations ofinsulin, the mean increase in Glu4:Tyrl phosphorylation over basal was 33% less (P < 0.05) in the NIDDM group than in controls. The concentration of insulin causing half-maximaI phosphorylation ofGlu4:Tyrl is most easily seen after recasting the insulin-stimulated kinase data of Fig. 8 A as a function of the percent of maximal effect. The results illustrated in Fig. 8 B, indicate that 3.6-fold more (P < 0.001) insulin was required to achieve a half-maximal effect in the NIDDM subjects than in either the control or obese subjects (control, 3.0±0.4; obese, 3.0±0.3; NIDDM, 11.0±0.4 ng/ml).
These results are expressed in terms of the concentration of total insulin added to the preincubation mixture. However, as we have reported previously (20), kinase data are more appropriately expressed as a function of the concentration of free insulin, because it is the concentration offree, and not total added, insulin that determines receptor occupancy. Furthermore, in a cell-free system such as ours, where relatively large numbers of insulin receptors are used to measure kinase activity, total added insulin may significantly overestimate the free insulin concentration, particularly at low concentrations oftotal insulin. When the kinase data from Fig. 8 B were recalculated in terms of free insulin concentrations, the half-maximal effect occurred at 1.1±0.2 ng/ml in the controls, 1.0±0.3 ng/ml in the obese, and 6.2±0.3 ng/ml in the NIDDM. Thus, a 5.6-fold higher (P < 0.001) concentration of free insulin was needed to achieve a Figure 9 . Correlation of insulin-stimulated autophosphorylation and insulin-stimulated Glu4: TyrI phosphorylation. Individual data for maximally insulin-stimulated autophosphorylation (Fig. 5) and Glu4: Ito Tyrl (Fig. 8 A) phos-)min phorylation are plotted. half-maximal effect in the NIDDM relative to the controls. Among receptors with equal insulin binding affinity, as is the case in our three groups, free insulin concentration directly determines receptor occupancy. Expression of kinase data in terms offractional receptor occupancy is a direct method for illustrating the effectiveness of bound insulin to stimulate Glu4:Tyrl phosphorylation. To emphasize the coupling of insulin binding to insulin-stimulated phosphorylation ofGlu4:Tyrl, the kinase data of Fig. 8 B were also replotted as a function of fractional receptor occupancy. The results, shown in Fig. 8 C, demonstrated a halfmaximal effect at 18±3% occupancy in the controls, 19+3% in the obese nondiabetics, and 38±4% (P < 0.001 vs. controls or obese) in the NIDDM. Thus, in terms of occupancy, 2.1-fold more receptor-bound insulin was required to reach a half-maximal effect in the NIDDM group than in either the control or obese group.
Correlation analyses. We hate previously shown that in some circumstances, autophosphorylation activity may differ from the kinase activity directed towards exogenous substrates (20). In the present study, both autophosphorylation and Glu4:Tyrl phosphorylation were reduced in NIDDM subjects relative to control and obese subjects. Furthermore, for individual subjects regardless of the experimental group, the magnitude of the effect of insulin to promote autophosphorylation was highly correlated (r = 0.85, P < 0.001) with the insulin-induced increase in Glu4: Tyrl phosphorylation as shown in Fig. 9 . The amount of autophosphorylation, Glu4:Tyrl phosphorylation, and insulin binding did not correlate significantly with fasting or integrated values of glucose and insulin measured during the OGTTs in the three groups, taken separately or combined.
Comparisons of the results of kinase activity iii our three groups is potentially complicated by the fact that the obese and NIDDM subjects were both older and fatter than the control group. It is well documented that insulin resistance characterizes obesity (21-24) and NIDDM (24-26) as well as human aging (48, 49) (particularly in subjects over 60 yr of age). Thus; the effect of age and obesity must both be taken into account when interpreting the kinase results of our NIDDM subjects. Clearly, obesity alone had no influence on receptor kinase activity, because the results were the same in the control and obese nondiabetic groups. The age ofour control subjects was significantly less (P < 0.01) than the age of the obese nondiabetic subjects. Nonetheless, the receptor kinase activity was comparable in both groups at all insulin concentrations (Figs. 5 and 8) . Moreover, within these two groups, taken separately or combined, neither age nor BMI correlated significantly with insulin-stimulated kinase activity. In an attempt to further address the issue of age, we compared the kinase activity in three obese subjects over 60 yr of age (63.3±1.7 yr) with the results of those under 60 yr (40.4±2.8 yr) and found that the maximal insulin-stimulated Glu4:Tyrl phosphorylation was 26.4±4.8 and 31.3±5.5 fmol phosphate/fmol insulin-binding activity/40 min (P, NS), respectively. Taken together, these findings suggest that within the range of age and BMI of subjects used for this study, neither age nor obesity were significant determinants ofkinase activity. The effect of diabetes per se on insulin receptor kinase activity was more easily determined by comparing the kinase results of the obese and NIDDM subjects whose ages and BMIs were comparable. Between these two groups, the kinase activity was markedly different.
Discussion
In the current study, we have presented evidence that insulin receptor tyrosine kinase activity is markedly impaired in NIDDM. This defect in enzyme function of the receptor was observed using two different phosphoacceptors, the ,3 subunit (autophosphorylation) of the receptor and the synthetic substrate Glu4:Tyrl. Within the range of age and obesity in our study groups, these factors did not contribute to the kinase defect. k-Thus, our NIDDM subjects displayed a receptor kinase defect compared to age-and obesity-matched nondiabetic subjects, who in turn had values for intrinsic kinase activity equal to lean, younger controls. Because obese, nondiabetic subjects are insulin resistant (21) (22) (23) (24) , as are NIDDM subjects (24) (25) (26) , it would appear that this postbinding defect in the intrinsic kinase activity ofthe insulin receptor is relatively specific for the hyperglycemic NIDDM state.
To strengthen this finding, we tried to exclude artifacts in the measurement of kinase activity. The reduction of kinase activity in NIDDM subjects could not be explained by ATPases or phosphatases, since under the conditions of our assays, the activities of these potential contaminants were negligible in all three groups. Moreover, it was unlikely that endogenous insulin, present in the fasting state in more than twice the concentration in NIDDM compared with controls, accounted for any difference in kinase activity since basal levels ofautokinase and exogenous substrate phosphorylating activity were equal in all three groups. Furthermore, basal insulin levels in the NIDDM group were equivalent to those of the obese nondiabetic group despite marked differences in kinase results between the two groups. In interpreting the current receptor kinase results, it is important to recall that all of our phosphorylation studies were conducted with equal insulin-binding capacities for all subjects. Thus, the reduction in insulin-stimulated kinase activity in the NIDDM subjects resulted from an overall reduction in intrinsic kinase activity per receptor. Since the binding affinity of insulin was identical in all three groups, equivalent amounts of insulin were bound to receptors at each concentration of added insulin. Therefore, for an equal amount ofbound insulin, insulin receptor kinase activity was markedly reduced in NIDDM, indicating that insulin binding is inefficiently coupled to the receptor kinase in NIDDM.
The cause for the reduced coupling efficiency in NIDDM is not yet clear. However, several explanations are possible. First, the ATP Km for autophosphorylation and Glu4:Tyrl phosphorylation could be higher for insulin receptors from NIDDM subjects. Since our assays were conducted at subsaturating concentrations of ATP, an increase in the ATP Km would result in less phosphate transferred to phosphoacceptors. Second, receptors from NIDDM subjects could possess a structural or conformational alteration in the , subunit that could either directly alter the active kinase site to reduce phosphate turnover or reduce available receptor phosphoacceptor sites critical for complete activation ofthe kinase. Recently, Burant et al. (18) demonstrated reduced kinase activity in association with an apparent posttranslational alteration in the structure ofinsulin receptors from skeletal muscles of rats made diabetic with streptozotocin. It is unlikely, however, that these types of structural alterations could be explained by proteolysis incurred during our receptor preparation because the isolation procedure, conducted at 40C, included proteolytic inhibitors and such modifications would have had to occur only in the NIDDM subjects, whose # subunit had a molecular weight identical to that observed in the control and obese subjects. Another possible explanation for the reduced coupling efficiency in NIDDM is that the signal generated in the a subunit by the binding of insulin may be inadequately transmitted to the ,3 subunit so that incomplete activation of the receptor kinase occurs. Finally, the maximal amount of 32P incorporated into a receptor preparation is a measure of the overall autophosphorylating capacity of the individual receptors. Thus, autophosphorylation may be reduced ifall receptors have reduced kinase activity or the preparation contains subpopulations of receptors where some incorporate virtually no phosphate while other incorporate normal amounts. In this regard, we cannot exclude the possibility that the reduced autophosphorylation and Glu4:Tyrl phosphorylation in receptors from NIDDM subjects is due to the presence ofsome receptors that bind insulin but have little, if any, kinase activity. Such a possibility could be due to preexisting phosphorylation of serine residues carried over from the in vivo state, as this has been shown to inhibit insulin stimulated receptor tyrosine kinase activity (13, 50).
The results ofGlu4:Tyrl phosphorylation in the three groups suggest that an additional, and possibly more complex, form of reduced coupling may characterize the reduced kinase activity observed in NIDDM. In addition to the overall diminished ability ofbound insulin to activate the receptor kinase, the results shown in Fig. 8 indicate that insulin bound at subsaturating concentrations activated the kinase less efficiently than insulin bound at maximally stimulating concentrations. The reason for this further uncoupling present at low insulin concentrations is unclear. Conceivably, insulin could cross-react with another tyrosine kinase at high, but not low, concentrations of insulin. As a consequence, Glu4:Tyrl phosphorylation measured at low concentrations of insulin would represent insulin receptor-mediated kinase activity, whereas phosphorylation of the peptide at saturating concentrations ofinsulin would be inappropriately high owing to the contribution from both kinases. This type of interaction would result in a shift to the right of the coupling curve. However, for several reasons this possibility seems remote. By far the most likely candidate for a receptor kinase of this sort is the IGF I receptor, which is known to phosphorylate Glu4: Tyrl (51) and can bind insulin when present in high concentrations (51, 52). However, adipocytes apparently lack IGF I receptors altogether (53) . Other candidates for such a receptor kinase include the EGF (54, 55) and IGF II (53) receptors. Although both of these receptor are present in adipocytes, neither binds insulin to any significant degree. Thus, it is unlikely that the uncoupling seen in Fig. 8 C is due to cross-reactivity of insulin with a tyrosine kinase separate from its own receptor. Instead, it is much more likely that the additional uncoupling is intrinsic to the insulin receptor itself. One possible explanation is the existence of different receptor subpopulations. Thus, a more extensive degree of uncoupling in the receptors occupied at low concentrations ofinsulin (high-affinity receptors) than in those occupied at high concentrations of insulin (low-affinity receptors) could explain the results. Recently, Heffetz et al. showed that receptor aggregation may play a role in activating the receptor kinase (56) . A greater reduction in receptor aggregation at low insulin concentrations could also explain the results. It is not clear why the uncoupling seen in Fig. 8 C was not also observed for the autophosphorylation results.
The amount of insulin-stimulated Glu4:Tyrl phosphorylation catalyzed by a receptor was highly correlated to its degree of insulin-stimulated autophosphorylation, regardless of the experimental group (Fig. 9 ). In the reaction used to measure Glu4: Tyrl phosphorylation, autophosphorylation, which supposedly serves to activate the insulin receptor kinase toward the exogenous substrate Glu4:Tyrl (7-10), proceeds simultaneously with phosphorylation ofthe peptide. Thus, it is possible that the Glu4: TyrI kinase activity is reduced in NIDDM as a consequence of the reduction in autophosphorylation. Because some or all of the tyrosine autophosphorylation of the ,B subunit is related to activation ofthe kinase toward exogenous substrates, one might Insulin Receptor Kinase Activity in Non-insulin-dependent Diabetics 247 then expect to see an increase in the rate of Glu4:Tyrl phosphorylation over time, particularly in NIDDM receptors, as sites on the l# subunit critical for enhanced kinase activity progressively autophosphorylate. In parallel studies, measuring rates of autophosphorylation (Fig. 4 A) and Glu4:Tyrl phosphorylation (Fig. 7) over prolonged periods of time in the three groups, we found a reduction in the maximal insulin-stimulated phosphorylation of the fl subunit in NIDDM subjects relative to the control and obese subjects. However, the sites necessary for activation of the kinase appeared to phosphorylate rapidly since the time course of Glu4:Tyrl phosphorylation did not depart from linearity. The rate of Glu4:Tyrl phosphorylation remained linear in the NIDDM subjects even when measured after 120 min, when maximal autophosphorylation had occurred in all three groups. Furthermore, the amount ofautophosphorylation at 120 min in the NIDDM group was equal to the amount of autophosphorylation in the obese and controls at -15 min. Nevertheless, the rate ofGlu4:Tyrl phosphorylation, from 120-165 min in the NIDDM group, was still decreased compared with that measured in the control and obese groups over an equivalent 45-min period of time from 15-60 min. Thus, even starting with equal amounts of autophosphorylation, the subsequent rate of Glu4:Tyrl phosphorylation was still decreased in NIDDM subjects, indicating that the reduction in Glu4:Tyrl phosphorylation in NIDDM was not secondary to decreased autophosphorylation. Rather, the findings reinforce our conclusion that NIDDM receptors have reduced insulin-stimulated kinase activity due to a reduction in the coupling efficiency of insulin binding to activation of the kinase.
Obese nondiabetic subjects are insulin resistant, as are NIDDM subjects. We have previously shown that the major cause ofinsulin resistance in both obesity and NIDDM involves postbinding defects in insulin action (24) . However, the sites of these defects may differ in the two conditions (33). In this regard, the current studies show a postbinding defect in intrinsic receptor kinase activity that appears to be relatively specific for NIDDM and not obesity. This represents the earliest postbinding event recognized so far in NIDDM. Furthermore, since activation of the receptor kinase is the earliest known postbinding step in insulin action, the potential relevance ofa defect in kinase activity to the etiology of insulin resistance in the N1DDM state is obvious. Thus, insofar as receptor kinase activity mediates insulin's ultimate biologic effects, the kinase defect in NIDDM could underly some or all of the postbinding aspects of insulin resistance in this condition.
Whether the kinase defect observed in the NIDDM group is primary or secondary is presently unknown. Clearly insulin receptor kinase defects can be acquired as shown by the development of altered receptor kinase activity secondary to streptozotocin diabetes (17), dietary manipulations in rats (20), and progressive obesity with hyperglycemia in mice (19). The cause of these acquired defects is unknown, but potential factors that could be involved are obesity and prevailing levels of insulin and glucose. In humans, the degree ofobesity does not correlate with the development ofdecreased kinase activity because obese and NIDDM subjects had similar BMIs but markedly different kinase activities. The role of hyperinsulinemia and hyperglycemia per se in the development of altered kinase activity is unclear (19, 20, 57) . Studies in NIDDM subjects before and after treatment and/or in fibroblasts cultured from these patients will help resolve the question of whether the kinase defect in NIDDM is acquired.
It is possible that the kinase defect in the NIDDM group reflects a subtle alteration in protein structure of the NIDDM insulin receptor, at least in some patients. In this event the kinase defect would be genetic rather than acquired. The tendency toward NIDDM is a familial trait whose expression is influenced by a variety of dietary and environmental factors. Thus, it is possible that a defect in kinase activity may be related to a primary genetic defect in the insulin receptor gene. Since the insulin receptor gene has recently been cloned and sequenced (5) , it is now possible to determine whether abnormalities of the gene exist and whether they are important in the development of NIDDM.
Insulin-stimulated tyrosine kinase activity has been found in insulin receptors extracted from a variety of cell and tissue types (8, 10, 16, 18-20, 44, 45, 57) , however, to date there have been no reports characterizing the insulin receptor kinase of human adipocytes. We have observed that, like the insulin receptor kinase described for other cells, insulin stimulated a 10-12-fold increase in tyrosine phosphorylation of the ,3 subunit of the receptor from human adipocytes in a dose and time-dependent fashion with a half-maximal effect achieved at 1-3 ng/ml free insulin. The time course of autophosphorylation proceeded 5-6 times more slowly in receptors derived from human adipocytes than in receptors from rat liver under identical phosphorylation conditions (20). A similar time course was observed in receptors from all three experimental groups. The reason for and the significance of this slower time course in human adipocytes is unknown.
